Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Xywav388.47M36.82%
Epidiolex/Epidyolex251.56M23.85%
Rylaze/Enrylaze98.78M9.36%
Zepzelca85.84M8.14%
Defitelio/defibrotide65.82M6.24%
High-sodium oxybate AG royalty revenue58.16M5.51%
Xyrem58.11M5.51%
Vyxeos34.31M3.25%
Other royalty and contract revenues7.11M0.67%
Other6.82M0.65%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States3.49B91.02%
Europe269.24M7.02%
All other74.98M1.96%
